Success Metrics

Clinical Success Rate
91.4%

Based on 32 completed trials

Completion Rate
91%(32/35)
Active Trials
4(6%)
Results Posted
31%(10 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_2
9
13%
Ph not_applicable
11
16%
Ph phase_4
26
39%
Ph phase_1
2
3%
Ph phase_3
16
24%

Phase Distribution

2

Early Stage

9

Mid Stage

42

Late Stage

Phase Distribution64 total trials
Phase 1Safety & dosage
2(3.1%)
Phase 2Efficacy & side effects
9(14.1%)
Phase 3Large-scale testing
16(25.0%)
Phase 4Post-market surveillance
26(40.6%)
N/ANon-phased studies
11(17.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.0%

32 of 41 finished

Non-Completion Rate

22.0%

9 ended early

Currently Active

4

trials recruiting

Total Trials

67

all time

Status Distribution
Active(5)
Completed(32)
Terminated(9)
Other(21)

Detailed Status

Completed32
unknown21
Withdrawn6
Terminated3
Recruiting2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
67
Active
4
Success Rate
91.4%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (3.1%)
Phase 29 (14.1%)
Phase 316 (25.0%)
Phase 426 (40.6%)
N/A11 (17.2%)

Trials by Status

recruiting23%
enrolling_by_invitation11%
withdrawn69%
active_not_recruiting23%
completed3248%
unknown2131%
terminated34%

Recent Activity

Clinical Trials (67)

Showing 20 of 67 trialsScroll for more
NCT05882708Phase 4

Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis

Recruiting
NCT02584439Phase 3

Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)

Completed
NCT04031573Phase 3

Ivabradine for Heart Rate Control In Septic Shock

Active Not Recruiting
NCT06305806Phase 2

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

Completed
NCT04853797Not Applicable

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)

Completed
NCT07268170Phase 2

Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease

Enrolling By Invitation
NCT05279651Phase 3

Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

Active Not Recruiting
NCT03168529Phase 4

Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit

Terminated
NCT03631654Phase 4

Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes

Withdrawn
NCT06670690Not Applicable

Comparison Between Atenolol,Propnalol and Ivabradine

Completed
NCT04285736Phase 2

Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI

Completed
NCT02446990Phase 3

Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure

Completed
NCT00202579Phase 2

Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

Completed
NCT06371222Phase 4

Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm

Completed
NCT06312891

Value of Heart Rate Lowering Therapy in Acute Myocarditis

Recruiting
NCT02973594Phase 4

Pulse Reduction On Beta-blocker and Ivabradine Therapy

Completed
NCT05481177Phase 4

Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

Unknown
NCT03718273Phase 3

IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).

Completed
NCT05261464Phase 4

Heart Rate Controller in Computed Tomography Coronary Angiography

Unknown
NCT05348057Phase 4

Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
67